A role for DNA hypomethylation and histone acetylation in maintaining allele-specific expression of mouse NKG2A in developing and mature NK cells

Journal of Immunology

Volumn 177, Issue 1, 2006, Pages 414-421

  Rogers, Sally L ^a   Rouhi, Arefeh ^a,b   Takei, Fumio ^a,b   Mager, Dixie L ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; DNA; HISTONE; HISTONE DEACETYLASE INHIBITOR; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; TRICHOSTATIN A;

ACETYLATION; ALLELE; ANIMAL CELL; ARTICLE; CELL KILLING; CELL MATURATION; CELL SELECTION; CELL TRANSPORT; CPG ISLAND; DNA METHYLATION; EX VIVO STUDY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 33745319035     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.1.414     Document Type: Article

References (47)

1. Braud, V. M., D. S. Allan, C. A. O'Callaghan, K. Soderstrom, A. D'Andréa, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, et al. 1998. HLA-E binds, to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795-799.
2. Vance, R. E., J. R. Kraft, J. D. Altman, P. E. Jensen, and D. H. Raulet. 1998. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188: 1841-1848.
3. Brennan, J., G. Mahon, D. L. Mager, W. A. Jefferies, and F. Takei. 1996. Recognition of class I major histocompatibility complex molecules by Ly-49: specificities and domain interactions. J. Exp. Med. 183: 1553-1559.
4. Chung, D. H., K. Natarajan, L. F. Boyd, J. Tormo, R. A. Mariuzza, W. M. Yokoyama, and D. H. Margulies. 2000. Mapping the ligand of the NK inhibitory receptor Ly49A on living cells. J. Immunol. 165: 6922-6932.
5. Hanke, T., H. Takizawa, C. W. McMahon, D. H. Busch, E. G. Pamer, J. D. Miller, J. D. Altman, Y. Liu, D. Cado, F. A. Lemonnier, et al. 1999. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11: 67-77.
6. Makrigiannis, A. P., A. T. Pau, A. Saleh, R. Winkler-Pickett, J. R. Ortaldo, and S. K. Anderson. 2001. Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J. Immunol. 166: 5034-5043.
7. Kelley, J., L. Walter, and J. Trowsdale. 2005. Comparative genomics of natural killer cell receptor gene clusters. PLoS Genet. 1: 129-139.
8. Moretta, L., and A. Moretta. 2004. Killer immunoglobulin-like receptors. Curr. Opin. Immunol. 16: 626-633.
9. Martin, A. M., E. M. Freitas, C. S. Witt, and F. T. Christiansen. 2000. The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics 51: 268-280.
10. Proteau, M. F., E. Rousselle, and A. P. Makrigiannis. 2004. Mapping of the BALB/c Ly49 cluster defines a minimal natural killer cell receptor gene repertoire. Genomics 84: 669-677.
11. Wilhelm, B. T., L. Gagnier, and D. L. Mager. 2002. Sequence analysis of the ly49 cluster in C57BL/6 mice: a rapidly evolving multigene family in the immune system. Genomics 80: 646-661.
12. Wilson, M. J., M. Torkar, A. Haude, S. Milne, T. Jones, D. Sheer, S. Beck, and J. Trowsdale. 2000. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl. Acad. Sci. USA 97: 4778-4783.
13. Chan, H. W., J. S. Miller, M. B. Moore, and C. T. Lutz. 2005. Epigenetic control of highly homologous killer Ig-like receptor gene alleles. J. Immunol. 175: 5966-5974.
14. Held, W., and B. Kunz. 1998. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire. Eur. J. Immunol. 28: 2407-2416.
15. Held, W., and D. H. Raulet. 1997. Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic. Eur. J. Immunol. 27: 2876-2884.
16. Held, W., J. Roland, and D. H. Raulet. 1995. Allelic exclusion of Ly49-family, genes encoding class I MHC-specific receptors on NK cells. Nature 376: 355-358.
17. Valiante, N. M., M. Uhrberg, H. G. Shilling, K. Lienert-Weidenbach, K. L. Arnett, A. D'Andrea, J. H. Phillips, L. L. Lanier, and P. Parham. 1997. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7: 739-751.
18. Chan, H. W., Z. B. Kurago, C. A. Stewart, M. J. Wilson, M. P. Martin, B. E. Mace, M. Carrington, J. Trowsdale, and C. T. Lutz. 2003. DNA methylation maintains allele-specific KIR gem: expression in human natural killer cells. J. Exp. Med. 197: 245-255.
19. Santourlidis, S., H. I. Trompeter, S. Weinhold, B. Eisermann, K. L. Meyer, P. Wernet, and M. Uhrberg. 2002. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J. Immunol. 169: 4253-4261
20. Uhrberg, M. 2005. Shaping the human NK cell repertoire: an epigenetic glance at KIR gene regulation. Mol. Immunol. 42: 471-475.
21. Rouhi, A., L. Gagnier, F. Takei, and D. Mager. 2006. Evidence for epigenetic maintenance of Ly49a mono-allelic gene expression. J. Immunol. 176: 2991-2999.
22. Silver, E. T., J. C. Lau, and K. P. Kane. 1999. Molecular cloning of mouse NKG2A and C. Immunogenetics 49: 727-730.
23. Marusina, A. I., D. K. Kim, L. D. Lieto, F. Borrego, and I. E. Coligan. 2005. GATA-3 is an important transcription factor for regulating human NKG2A gene expression. J. Immunol. 174: 2152-2159.
24. Gardiner-Garden, M., and M. Frommer. 1987. CpG islands in vertebrate genomes. J. Mol. Biol. 196: 261-282.
25. Yamashita, R., Y. Suzuki, S. Sugano, and K. Nakai. 2005. Genome-wide analysis reveals strong correlation between CpG islands with nearby transcription start sites of genes and their tissue specificity. Gene 350: 129-136.
26. Vance, R. E., A. M. Jamieson, D. Cado, and D. H. Raulet. 2002. Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation. Proc. Natl. Acad. Sci. USA 99: 868-873.
27. Warnecke, P. M., C. Stirzaker, J. Song, C. Grunau, J. R. Melki, and S. J. Clark. 2002. Identification and resolution of artifacts in bisulfite sequencing. Methods 27: 101-107.
28. Bird, A. P., and A. P. Wolffe. 1999. Methylation-induced repression: belts, braces, and chromatin. Cell 99: 451-454.
29. Smith, M. M. 1991. Histone structure and function. Curr. Opin. Cell Biol. 3: 429-437.
30. Liu, Q., F. Xie, S. L. Siedlak, A. Nunomura, K. Honda, P. I. Moreira, X. Zhua, M. A. Smith, and G. Perry. 2004. Neurofilament proteins in neurodegenerative diseases. Cell Mol. Life Sci. 61: 3057-3075.
31. Lian, R. H., M. Maeda, S. Lohwasser, M. Delcommenne, T. Nakano, R. E. Vance, D. H. Raulet, and F. Takei. 2002. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro. J. Immunol. 168: 4980-4987.
32. Rosmaraki, E. E., I. Douagi, C. Roth, F. Colucci, A. Cumano, and J. P. Di Santo. 2001. Identification of committed NK cell progenitors in adult murine bone marrow. Eur. J. Immunol. 31: 1900-1909.
33. Kim, S., K. Iizuka, H. S. Kang, A. Dokun, A. R. French, S. Greco, and W. M. Yokoyama. 2002. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3: 523-528.
34. Williams, N. S., A. Kubota, M. Bennett, V. Kumar, and F. Takei. 2000. Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression. Eur. J. Immunol. 30: 2074-2082.
35. Razin, A. 1998. CpG methylation, chromatin structure and gene silencing: a three-way connection. EMBO J. 17: 4905-4908.
36. Lorincz, M. C., D. R. Dickerson, M. Schmitt, and M. Groudine. 2004. Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells. Nat. Struct. Mol. Biol. 11: 1068-1075.
37. Lee, D. U., S. Agarwal, and A. Rao. 2002. Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. Immunity 16: 649-660.
38. Kubota, A., S. Kubota, S. Lohwasser, D. L. Mager, and F. Takei. 1999. Diversity of NK cell receptor repertoire in adult and neonatal mice. J. Immunol. 163: 212-216.
39. Dorfman, J. R., and D. H. Raulet. 1998. Acquisition of Ly49 receptor expression by developing natural killer cells. J. Exp. Med. 187: 609-618.
40. Maeda, M., N. Uchida, C. J. Eaves, and F. Takei. 2003. Slow receptor acquisition by NK cells regenerated in vivo from transplanted fetal liver or adult bone marrow stem cells. Exp. Hematol. 31: 1015-1018.
41. Imamura, M., Y. Tsutsumi, Y. Miura, T. Toubai, and J. Tanaka. 2003. Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantation. Hematology 8: 19-26.
42. Nguyen, S., N. Dhedin, J. P. Vernant, M. Kuentz, A. Al Jijakli, N. Rouas-Freiss, E. D. Carosella, A. Boudifa, P. Debre, and V. Vieillard. 2005. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood 105: 4135-4142.
43. Shilling, H. G., K. L. McQueen, N. W. Cheng, J. A. Shizuru, R. S. Negrin, and P. Parham. 2003. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 101: 3730-3740.
44. Vitale, C., A. Pitto, F. Benvenuto, M. Ponte, R. Bellomo, F. Frassoni, M. C. Mingari, A. Bacigalupo, and L. Moretta. 2000. Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors. Hematol. J. 1: 136-144.
45. Colucci, F., M. A. Caligiuri, and J. P. Di Santo. 2003. What does it take to make a natural killer? Nat. Rev. Immunol. 3: 413-425.
46. Miller, J. S., and V. McCullar. 2001. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood 98: 705-713.
47. Shilling, H. G., N. Young, L. A. Guethlein, N. W. Cheng, C. M. Gardiner, D. Tyan, and P. Parham. 2002. Genetic control of human NK cell repertoire. J. Immunol. 169: 239-247.